| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/25/2006 | US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia |
| 05/25/2006 | US20060111294 Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells |
| 05/25/2006 | US20060111293 Antagonists for human prolactin |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111286 Method of modulating endothelial cell activity |
| 05/25/2006 | US20060111284 Method for treating cancer |
| 05/25/2006 | US20060111278 TFF peptides |
| 05/25/2006 | US20060111235 Method of manufacturing ferromagnetic particle exothermic elements |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110473 Composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 05/25/2006 | US20060110465 Compositions addressing inflammation and/or degenerative disorders |
| 05/25/2006 | US20060110443 toxic or potent core is incorporated into the dosage form via three-dimensional printing, as a solution, solubilization or suspension of solid particles in liquid, rather than by the more conventional handling and compressing of dry powder; allows greater bioavailability |
| 05/25/2006 | US20060110436 Phospholipid derivative |
| 05/25/2006 | US20060110393 Novel proteins and use thereof |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110363 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/25/2006 | US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 05/24/2006 | EP1659179A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659178A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 05/24/2006 | EP1659177A2 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 05/24/2006 | EP1659176A1 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1659113A1 Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
| 05/24/2006 | EP1658856A1 Exendins for glucagon suppression |
| 05/24/2006 | EP1658852A1 Oral pharmaceutical preparation containing ibandronat |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658848A1 Formulations comprising ecteinascidin and a disaccharide |
| 05/24/2006 | EP1658290A2 Compounds and compositions as protein kinase inhibitors |
| 05/24/2006 | EP1658284A1 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/24/2006 | EP1658274A2 Inhibitors of cathepsin s |
| 05/24/2006 | EP1658267A2 Inhibitors of cathepsin s |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1658255A2 Proteasome inhibitors and methods of using the same |
| 05/24/2006 | EP1658097A1 Nucleotide and cellular vaccine composition |
| 05/24/2006 | EP1658084A2 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer |
| 05/24/2006 | EP1658081A2 Immunosuppressive effects of pteridine derivatives |
| 05/24/2006 | EP1658080A1 Dosing schedule for a erbb2 anticancer agents |
| 05/24/2006 | EP1658076A1 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 05/24/2006 | EP1658075A2 Composition and method for the treatment of cancer and other physiologic conditions based on modulation of the ppar-gamma pathway and her-kinase axis |
| 05/24/2006 | EP1658068A1 Novel cycloalkyl'b! condensed indoles |
| 05/24/2006 | EP1565176B1 Agent having a destructive effect on malignant tumors and method for the production thereof |
| 05/24/2006 | EP1551850B1 2" oxo-voruscharin and derivatives thereof |
| 05/24/2006 | EP1508333B1 Novel therapeutic use of riboside of 5-aminoimidazole-4- carboxamide (acadesine) |
| 05/24/2006 | EP1501812A4 Pna monomer and precursor |
| 05/24/2006 | EP1487452B1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl -benzamide for treating seminomas |
| 05/24/2006 | EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1466614A4 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1384477B1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 05/24/2006 | EP1373305B1 Process for producing trunkamide a compounds |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | EP1341778B1 Klainetin and derivatives thereof, method for their production and the use of the same |
| 05/24/2006 | EP1334106B1 Imidazole derivatives, production method thereof and use thereof |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1259520B1 Novel purines |
| 05/24/2006 | EP1242102B1 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 05/24/2006 | EP1226129B1 Methods and compositions utilizing quinazolinones |
| 05/24/2006 | EP1115397B1 Compositions for mitigating the adverse effects of interleukin-2 |
| 05/24/2006 | EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 05/24/2006 | EP1039887B1 Use of aminothiol compounds for the treatment of neuro- and nephro-disorders and therapeutic toxicities |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0907733B1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | EP0813539B1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 05/24/2006 | DE102004055998A1 Niedermolekulare Inhibitoren von Guaninnucleotid-Austauschfaktoren der Cytohesin-Familie Small-molecule inhibitors of guanine nucleotide exchange factors of the cytohesin family |
| 05/24/2006 | DE102004055891A1 Kit for treating cancer, autoimmune diseases, immune deficiency diseases, and as accompanying therapy for bacterial and viral infections, comprises a mixture of snake toxins from at least three different types of snakes |
| 05/24/2006 | DE102004054847A1 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 05/24/2006 | CN1777672A Recombinant virus comprising tumour therapeutic full-antibody gene with human constant region and its use |
| 05/24/2006 | CN1777622A Modulation of the poliovirus receptor function |
| 05/24/2006 | CN1777618A 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos |
| 05/24/2006 | CN1777614A Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/24/2006 | CN1777611A Novel process for the preparation of hexacyclic camptothecin |
| 05/24/2006 | CN1777603A Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 05/24/2006 | CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/24/2006 | CN1777590A Indazole derivatives |
| 05/24/2006 | CN1777446A A medicament for the two-step perioperative therapy of solid tumours |
| 05/24/2006 | CN1777424A Antineoplastic combination drug |
| 05/24/2006 | CN1777413A Mmp expression inhibitor |
| 05/24/2006 | CN1775952A New use of high-expressed human portein in androgen dependent/non-dependent prostatic cancer for prostatic tumour diagnosis and therapeutic prognosis |
| 05/24/2006 | CN1775947A Recombinant adenovirus capable of expressing tomour specific apoptosis peptide, and its preparing method and use |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1775813A Carboxy methyl schizophllan polysacharide preparing method and its use for use in cosmetics and anticancer drugs |
| 05/24/2006 | CN1775808A Anti CD19 engineered antibody for target conjugated lymphocyte, leuco cyte and its use |
| 05/24/2006 | CN1775802A Human papillomavirus immunogenic polypeptide, and its preparing method and use |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1775286A Vaccine for preventing and/or treating tumour of digestive system |
| 05/24/2006 | CN1775267A Kaikoujian extract, Its preparing method and use |
| 05/24/2006 | CN1775250A Anti-cancer preparation-kangaiping, new preparing method therefor |
| 05/24/2006 | CN1775226A Use of attenuated salmonella carraying human PF4 gene for chemotherapeutic protection and hematopoietic reconstitution |
| 05/24/2006 | CN1775223A Compound arsenic trioxide injection |
| 05/24/2006 | CN1775218A Cyclophosphamide liposome and its preparing method |
| 05/24/2006 | CN1775216A New formulation oxaliplatin liposome |
| 05/24/2006 | CN1257286C Targeted adenovirus vectors for delivery of heterologous genes |
| 05/24/2006 | CN1257187C Calreticulin-tumor necrosis factor correlated apoptosis inducing ligand fusion protein and its prearation and use |
| 05/24/2006 | CN1257186C Interferon gamma polypeptide variants |
| 05/24/2006 | CN1257183C Hard clam extract, and preparing process and use thereof |